Advanced Medical Optics

The combination of these complementary technologies has made “all-laser LASIK” possible. In August 2007 the company donated $2.5 million to UC-Irvine’s Department of Ophthalmology to boost the university’s planned Eye Institute. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide.

The documents show Advanced Medical Optics received complaints about the solution more than a year before it was recalled, and failed to promptly report nine complaints as required by law. Whitestar Signature with Fusion Fluidics . for $808 million in January 2007.

The voluntary and limited recall was caused by an isolated production line problem that affected two of the four production lines in the AMO facility, not because of a formulation issue. In February 2009 Abbott completed its acquisition of Advanced Medical Optics AMO voluntarily recalled some of their products in 2006 due to a bacterial contamination in the factory process which would have compromised sterility.

Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. This happened in the midst of a recall scare period caused by Bausch & Lomb s worldwide product recall, after eye care doctors in Singapore traced 90% of their patients eye infections, some to the serious extent of causing blindness, to B&L products.

Non-sterility of a contact lens solution may have serious health consequences, including eye infection and microbial keratitis. earlier known as Advanced Medical Optics, Inc.

In fact, no reports of adverse health effects due to the suspected-affected batch of products were made to AMO. In some countries, there were initial confusion between B&L s product dangers and AMO s voluntary recall. In May 2007, the Centers for Disease Control and Prevention linked AMO MoisturePlus eye solution to Acanthamoeba keratitis infections. On June 20, 2009 The Associated Press published an article titled, Contact Solution Maker Failed to Report Problems. The article states, Complaints about a contact lens solution linked to a 2007 outbreak of eye infections that blinded several people went unreported by the manufacturer for more than a year, government documents show.

Abbott Medical Optics Inc. This allowed AMO to combine IntraLase technology for cutting a flap in the cornea with AMO technology for reshaping the cornea.

(Also known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. The company has operations in 24 countries and markets products in approximately 60 countries. AMO was spun off from Allergan in 2002. AMO bought Irvine-based IntraLase Corp.